Dudediligence.

iSpecimen Inc

ISPCNASDAQ · Services-Commercial Physical & Biological Research
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.7MSep ’24$1.5MDec ’24$1.1MMar ’25$713,135Jun ’25$106,592Sep ’25$51,761Dec ’25$156,009Mar ’26$151,940Jun ’26
Net income, by quarter
−$1.4MSep ’24−$6.0MDec ’24−$1.7MMar ’25−$1.0MJun ’25−$2.8MSep ’25−$5.0MDec ’25−$2.3MMar ’26−$1.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$11.1M$10.4M$9.9M$9.3M$1.9M
Gross profit$5.9M$5.6M$5.1M$4.0M$215,665
Operating income−$5.9M−$10.2M−$11.2M−$12.7M−$9.0M
Net income−$9.0M−$10.2M−$11.1M−$12.5M−$10.5M
Operating cash flow−$10.7M−$5.8M−$5.8M−$8.3M−$4.2M
Free cash flow−$10.7M−$6.0M−$5.8M−$8.3M−$4.2M
Cash$27.7M$15.3M$2.3M$1.9M$6.9M
Debt$3.4Mnone on filenone on filenone on filenone on file
Shares outstanding8.7M8.9M454.2K1.7M8.5M